Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
Condition(s):Drug InteractionsLast Updated:March 18, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Drug InteractionsLast Updated:March 18, 2024Completed
Condition(s):Hepatic ImpairmentLast Updated:March 18, 2024Recruiting
Condition(s):Primary Myelofibrosis; Post-Polycythemia Vera Myelofibrosis; Post- Essential Thrombocythemia MyelofibrosisLast Updated:June 1, 2022Completed
Condition(s):COVID19; COVID-19; COVIDLast Updated:July 5, 2023Terminated
Condition(s):Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia MyelofibrosisLast Updated:February 20, 2024Recruiting
Condition(s):HealthyLast Updated:September 15, 2023Completed
Condition(s):Healthy SubjectsLast Updated:September 15, 2023Completed
Condition(s):Healthy SubjectsLast Updated:September 15, 2023Completed
Condition(s):Healthy SubjectsLast Updated:September 15, 2023Completed
Condition(s):MyelofibrosisLast Updated:October 22, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.